To include your compound in the COVID-19 Resource Center, submit it here.

Pyridorin: BioStratum completed enrollment of an ongoing U.S. Phase II safety study (trial PYR-206) in 128 Type I and II patients.

BioStratum Inc., Research Triangle Park, N.C.

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE